Remedica, LLC

Rochester, Michigan 48307

0 studies enrolling now · 9 studies all time

What they study most

Cardiovascular Disease, Chronic Disease, Chronic Idiopathic Constipation, Diabetes Mellitus, Type 2, High Cardiovascular Risk, Influenza, Nocturia, Obesity, Overactive Bladder, Overweight, Pain, Type 2 Diabetes

Studies at this site

• A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
• Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women — Completed
• Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary — Completed
• Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients — Completed
• Conversion to Embeda With Rescue Trial — Stopped early
• Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults — Status unconfirmed